Inspection & Audit Management
Biostrategenix makes inspections predictable, not painful by helping you prepare with confidence, respond decisively, and close out issues fast. From audit prep and mock inspections to 483/deficiency responses, remediation, and Annex 1 compliance, we safeguard and enhance your regulatory compliance standing, protect market access, and keep your business moving forward.
Our Services
Regulatory inspections can make or break a company’s reputation. Response to regulatory findings may also significantly impact corporate strategic timelines, and eventually bottom line. At Biostrategenix, we help pharmaceutical and biopharmaceutical firms prepare for audits with confidence, respond with precision, and close out issues quickly so you stay inspection-ready, avoid costly delays, and protect market access.
- Audit Preparation – End-to-end support for Pre-Approval, Surveillance, For-Cause, Follow-Up/Re-Inspection, Compliance, and Post-Approval inspections to ensure you meet regulatory expectations the first time.
- Mock Inspections & Readiness Training – Realistic simulations and targeted coaching that equip your teams to perform with confidence under pressure.
- 483 & Deficiency Response – Clear, defensible, and regulator-credible responses that minimize business disruption and restore confidence.
- Remediation & Warning Letter Closeout – Rapid, structured programs to fix gaps, prevent recurrence, and regain regulatory trust.
- Annex 1 Assessment – Expert evaluation of sterile operations to ensure alignment with the latest EU requirements and avoid costly compliance risks.
We go beyond “check-the-box” readiness. Biostrategenix helps you turn regulatory agency inspections into opportunities to demonstrate control, resilience, and operational excellence while protecting revenue and patient trust.